NCT07101861Completed
Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
The overall object of this project is to test the feasibility and acceptability of an adapted stress management enhanced behavioral weight loss intervention for Black breast cancer survivors with obesity and elevated stress. We will also conduct pre- and post-intervention assessments of weight, allostatic load, and patient reported outcomes among study participants.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 37 (actual)
- First submitted
- 28 Jul 2025
- Start date
- 20 Jan 2024
- Primary completion date
- 7 Jun 2025
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Diseases
- Obesity
- NCT number
- NCT07101861
What you commit to
- Study type: Interventional
- Participants enrolled: 37
- From 20 Jan 2024 to the primary completion date, 7 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of psychiatric hospitalization in past 2 years.
- History of substance abuse or eating disorder.
- Any other condition by which a medical professional has suggested diet modification, physical activity, and/or weight loss would be contraindicated.
Lab values
- Have a known major medical or psychological condition known to influence weight loss \[e.g., medicated or poorly controlled diabetes (HbA1c \> 8%), uncontrolled hypertension (BP\>160 mm Hg systolic or BP\>100 mm Hg diastolic), cardiovascular event in the past 12 months, history of gastric bypass or bariatric surgery\].
Other
- Are pregnant or are planning to become pregnant during the study period.
Who the study is looking for
- Self-identify as non-Hispanic Black
- Self-identify as cisgendered female.
- Are ≥ age 18.
- Have a history of stage 0-3 breast cancer diagnosis treated for curative intent.
- Have completed all adjuvant or neoadjuvant chemotherapy, radiation, and surgery at least 21 days prior to study registration but may continue on hormonal therapy and Abemaciclib therapy.
- Have a measured BMI ≥ 30 kg/m2.
- Willing to participate for the entire 4-month duration.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Moffitt Cancer Center Coordinator of this site? Confirm its status | Tampa | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.